Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

13.360
0.000
Volume:2.59M
Turnover:35.00M
Market Cap:7.94B
PE:-75.37
High:13.980
Open:13.640
Low:13.310
Close:13.360
52wk High:28.600
52wk Low:10.870
Shares:594.00M
HK Float Shares:594.00M
Volume Ratio:0.66
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.177
ROE:-9.57%
ROA:-8.91%
PB:6.18
PE(LYR):-75.37
PS:49.80

Loading ...

CarsGen-B Showcases Clinical Data for CT0596 and CT1190B at EHA 2026 Congress

Stock News
·
Jun 15

CARsgen presents updated EHA data from CT0596 allogeneic BCMA CAR-T study in relapsed/refractory multiple myeloma

Reuters
·
Jun 15

Movement Alert|CARsgen Therapeutics Rises 5.72% in Regular Trading, In Vivo CAR-T Sector Momentum Fuels Rally

Market Focus
·
Jun 10

CARsgen issues 23.73 million new shares in May; total share count rises 4.16 %, public float intact

Bulletin Express
·
Jun 04

Movement Alert|CARsgen Therapeutics-B Declines 5.14% in Regular Trading, Discounted Placement Dilution and Biotech Sector Weakness Continue to Pressure Shares

Market Focus
·
Jun 02

Movement Alert|CARsgen Therapeutics-B Declines 5.02% in Regular Trading, Discounted Placement Dilution and Institutional Selling Continue to Pressure Shares

Market Focus
·
Jun 01

Long-Term Analysis of CT041 (Satricabtagene Autoleucel) in Advanced Gastric Cancer Presented at 2026 ASCO Annual Meeting

Stock News
·
Jun 01

Long-Term Follow-up Results of CARsgen's Satri-Cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 Asco Annual Meeting

THOMSON REUTERS
·
Jun 01

CARsgen presents long-term ASCO data on satri-cel sequential therapy in advanced gastric cancer subgroup analysis

Reuters
·
Jun 01

Movement Alert|CARsgen Therapeutics Rises 5.47% in Regular Trading, Biotech Sector Rally and Solid Tumor CAR-T Milestone Boost Sentiment

Market Focus
·
May 29

Movement Alert|CARsgen Therapeutics-B Declines 5.19% in Regular Trading, Dilutive Impact of Discounted Placement Continues to Pressure Stock

Market Focus
·
May 28

CARsgen Therapeutics boosts share capital by 4.15% through HKD 19.84 placement and option exercises

Bulletin Express
·
May 26

CARSGEN-B (02171) Finalizes Placement of 23.7 Million Shares via Top-Up Offering, Raising Approximately HK$462 Million Net

Stock News
·
May 26

CARsgen Therapeutics completes HK$470.21 million top-up share placement at HK$19.84 each

Reuters
·
May 26

Movement Alert|CARsgen Therapeutics-B Falls 5.2% in Regular Trading, Discounted Placement and Innovative Drug Sector Weakness Weigh on Shares

Market Focus
·
May 26

CARsgen Updates Governance Framework with Ninth Amended & Restated Articles

Bulletin Express
·
May 22

CARsgen shareholders adopted 2025 audited financial statements at annual meeting

Reuters
·
May 22

CARsgen Issues Clarification, Adds Directors’ Responsibility Statement to 23.70 Million-Share Top-Up Placing Notice

Bulletin Express
·
May 22

CARsgen issues clarification on top-up placing announcement, adds directors’ responsibility statement

Reuters
·
May 22

Major Shareholder of CARSGEN-B (02171) Transfers HK$432 Million Worth of Shares from UBS to Citibank

Stock News
·
May 20